NZ757754A - Antibodies that bind csf1r - Google Patents

Antibodies that bind csf1r

Info

Publication number
NZ757754A
NZ757754A NZ757754A NZ75775411A NZ757754A NZ 757754 A NZ757754 A NZ 757754A NZ 757754 A NZ757754 A NZ 757754A NZ 75775411 A NZ75775411 A NZ 75775411A NZ 757754 A NZ757754 A NZ 757754A
Authority
NZ
New Zealand
Prior art keywords
antibodies
bind csf1r
csf1r
disclosed
bind
Prior art date
Application number
NZ757754A
Inventor
Justin Wong
Maximiliano Vasquez
Original Assignee
Five Prime Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc filed Critical Five Prime Therapeutics Inc
Publication of NZ757754A publication Critical patent/NZ757754A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Disclosed is an isolated antibody comprising the sequences as defined in the specification that binds colony stimulating factor 1 receptor (CSF1R). Also disclosed is its use in treatment.
NZ757754A 2010-05-04 2011-05-04 Antibodies that bind csf1r NZ757754A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33117710P 2010-05-04 2010-05-04
NZ72753111 2011-05-04

Publications (1)

Publication Number Publication Date
NZ757754A true NZ757754A (en) 2023-03-31

Family

ID=86613254

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ757754A NZ757754A (en) 2010-05-04 2011-05-04 Antibodies that bind csf1r

Country Status (1)

Country Link
NZ (1) NZ757754A (en)

Similar Documents

Publication Publication Date Title
NZ626610A (en) Antibodies that bind csf1r
MX357391B (en) Anti-erbb3 antibodies and uses thereof.
NZ700891A (en) 4-1bb binding molecules
PH12014501164A1 (en) Anti-cd98 antibodies and methods of use thereof
NZ599737A (en) Il-17a antagonists
NZ594339A (en) Anti-fgfr3 antibodies and methods using same
EA201400579A1 (en) ANTIBODIES TO IL-36R
MX2019009654A (en) Folate receptor 1 antibodies and immunoconjugates and uses thereof.
AU2011338480A8 (en) Humanized antibodies to LIV-1 and use of same to treat cancer
EA201890548A1 (en) ANTIBODIES TO IL-23
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
NZ611785A (en) Anti-notch1 antibodies
MX2013011479A (en) Anti-fgfr4 antibodies and methods of use.
MX336001B (en) Anti-axl antibodies and methods of use.
GB2488091A (en) Humanized anti-interleukin 3 receptor alpha chain antibodies
MX2014004022A (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE.
MX346500B (en) Methods and compositions for neural disease immunotherapy.
MX340555B (en) Antibodies against il-18r1 and uses thereof.
MX336323B (en) Anti-polyubiquitin antibodies and methods of use.
MX343580B (en) Antibodies against g-csfr and uses thereof.
MX2016005854A (en) Neuregulin allosteric anti-her3 antibody.
NZ757754A (en) Antibodies that bind csf1r
NZ599097A (en) Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
TR201905240T4 (en) Humanized antibodies to LIV-1 and their use in the treatment of cancer.
TN2011000545A1 (en) Vinyl indazolyl compounds

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 9 YEARS UNTIL 04 MAY 2024 BY AJ PARK

Effective date: 20230906